Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03575377
Other study ID # IRB18-00157
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 7, 2018
Est. completion date December 31, 2018

Study information

Verified date March 2019
Source Nationwide Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Opioids are an important component of post-operative pain management among children, but are often prescribed in excess and rarely disposed of appropriately. The lack of prompt and proper opioid disposal after recovery from surgery is contributing to the opioid crisis in Ohio by placing children at risk of accidental ingestion of opioids remaining in the home and allowing for unused opioids to be diverted for non-medical use. The investigators propose to reduce the burden of the opioid crisis in Ohio by testing a strategy to increase proper opioid disposal by families of children undergoing outpatient surgery. The investigators will test the impact of a novel opioid disposal mechanism, the Deterra® drug deactivation system, after pediatric surgical operations. This system deactivates pills, liquids, or patches, allowing for their disposal in the home garbage. The investigators propose to evaluate the effectiveness of providing Deterra® bags to families of children having surgery on their disposal of excess opioids. The investigators will perform a randomized controlled trial (RCT) to test the effectiveness of Deterra® to improve opioid disposal among families of children having outpatient surgery at Nationwide Children's Hospital.


Description:

Opioids are an important component of post-operative pain management among children, but are often prescribed in excess and rarely disposed of appropriately. The lack of prompt and proper opioid disposal after recovery from surgery is contributing to the opioid crisis in Ohio by placing children at risk of accidental ingestion of opioids remaining in the home and allowing for unused opioids to be diverted for non-medical use. The investigators propose to reduce the burden of the opioid crisis in Ohio by testing a strategy to increase proper opioid disposal by families of children undergoing outpatient surgery. The investigators will test the impact of a novel opioid disposal mechanism, the Deterra® drug deactivation system, after pediatric surgical operations. This system deactivates pills, liquids, or patches, allowing for their disposal in the home garbage. The investigators propose to evaluate the effectiveness of Deterra® for opioid disposal among families of Ohio children having surgery. The investigators will perform a randomized controlled trial (RCT) to test the effectiveness of Deterra® to improve proper opioid disposal among families of children having outpatient surgery at Nationwide Children's Hospital.

The goal of this project is to evaluate the impact of providing the Deterra® drug deactivation system on the excess opioid disposal rate among families of children having outpatient otolaryngologic or urologic surgery at NCH. A second objective of this study is to evaluate whether the impact of the Deterra® drug deactivation system varies by parent/guardian health literacy level or signing of an "opioid consent form" acknowledging that they will follow appropriate dosing recommendations, not give opioids if their child appears sleepy, not give Tylenol concurrently with Tylenol-containing opioid medications, dispose of unused opioids safely and responsibly, and contact their child's surgeon's office or the on-call physician with any questions. To accomplish these objectives, the investigators will perform a randomized controlled trial comparing groups of patients who receive either 1) a Deterra® bag along with brief instruction on how and why to use it along with routine postoperative instructions or 2) routine postoperative instructions.

The investigators plan to enroll 202 caregivers of children having outpatient surgery. All families will receive a 1-page pain journal to record the child's opioid and non-opioid adjunct pain medication administration. In addition to the instructions provided by the care team as described above, families randomized to the intervention arm will additionally receive a Deterra® bag and instructions on its use by a research team member.

In order to minimize disruption to the clinical work flow, minimal data will be collected at baseline directly from enrolled families. This will include the contact information required for follow-up, a limited set of research related questions, and a brief assessment of parent/guardian health literacy. Baseline demographic and clinical characteristics of the child, such as their primary payer, residential address, age, and comorbidities at the time of surgery will be extracted from the electronic medical record.

Parents/guardians will be contacted by their preferred method of email survey or phone call at 2 weeks postoperatively, at which time they will be surveyed on their child's postoperative opioid and non-opioid medication use, opioid storage location, quantity of opioid remaining, disposal method, and any barriers to disposal. If the child continues to require opioids, they will be contacted again at 4 weeks postoperatively. If the parent believes that their older child or adolescent can assist in answering the survey questions, they will be encouraged to complete the survey together. The primary outcome of this trial is the proper disposal of unused opioids. Secondary outcomes include the quantities of opioid used and leftover after surgery, opioid storage location, disposal by any method, and barriers to disposal.


Recruitment information / eligibility

Status Completed
Enrollment 202
Est. completion date December 31, 2018
Est. primary completion date December 31, 2018
Accepts healthy volunteers No
Gender All
Age group 1 Year to 17 Years
Eligibility Inclusion Criteria:

- Parent or legal guardian of a child having outpatient otolaryngologic or urologic surgery at Nationwide Children's Hospital

- Child's age is between 1 and 17 years

- Child is expected to receive a discharge opioid prescription

Exclusion Criteria:

•Unable or unwilling to track pain medication use or complete a follow-up survey

Study Design


Intervention

Other:
Disposal Aid
Deterra® drug deactivation system

Locations

Country Name City State
United States Jennifer Cooper Columbus Ohio

Sponsors (2)

Lead Sponsor Collaborator
Nationwide Children's Hospital Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proper disposal of unused opioids The proper disposal of unused opioids, defined as the disposal of unused opioids by an FDA-recommended method or by using the Deterra® drug deactivation system. 2-4 weeks
Secondary Quantity of opioid used after surgery Number of doses of opioid pain medication used after surgery 2-4 weeks
Secondary Quantity of opioid leftover after surgery Number of doses of opioid pain medication leftover after surgery 2-4 weeks
Secondary Proper storage of opioids Whether the opioids were properly stored after surgery 2-4 weeks
Secondary Barriers to opioid disposal What the parent/caregiver perceived as barriers to their disposal of their child's opioids after surgery 2-4 weeks
Secondary Disposal of unused opioids by any method Disposal of unused opioids by any recommended or non-recommended method 2-4 weeks
See also
  Status Clinical Trial Phase
Completed NCT01629485 - Part vs Whole Task Mastery Training for Laparoscopic Hernia Repair N/A
Terminated NCT01305486 - A Study of Complex Ventral Hernia Repair Utilizing the XenMatrix™ Surgical Graft With Component Separation N/A
Completed NCT01205399 - A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repair Utilizing the AlloMax Surgical Graft N/A
Completed NCT00905320 - Hernia Repair With or Without Sutures N/A
Completed NCT01141335 - Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair Phase 4
Completed NCT00535990 - Minimally Invasive Surgery (MIS) Database for the Purpose of Research
Completed NCT00617357 - Repair of Infected or Contaminated Hernias N/A
Withdrawn NCT00138957 - Study of a New Laparoscopic Technique for Parastomal Hernia Repair With Mesh N/A
Completed NCT06034652 - T-GENVIH-003 LTFU (Long Term Follow Up) Study
Completed NCT06389331 - Study on Effects of Defect Closure in Laparoscopic Repair of Direct Inguinal Hernia
Completed NCT04119466 - Stabilizing Training in Degenerative Disc Disease N/A
Completed NCT00622583 - International Hernia Mesh Registry
Completed NCT04137172 - Short Term Outcomes of Laparoscopic Intraperitoneal Onlay Mesh With Facial Repair(IPOM-plus) for Ventral Hernia. N/A
Completed NCT01132209 - Suture Techniques to Reduce the Incidence of The inCisional Hernia N/A
Completed NCT00032448 - Does Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients? Phase 3
Not yet recruiting NCT05061589 - Incidence and Risk Factors of Parastomal Hernia in Patients With Permanent Colostomy in China
Active, not recruiting NCT02439060 - PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit) N/A
Completed NCT01727388 - Informativeness to Digital Rectal Examination Phase 3
Completed NCT02238964 - Reinforcement of Closure of Stoma Site Phase 2/Phase 3
Completed NCT01997619 - Biological Mesh Repair of Complex Hernias in High Risk Patients N/A